Memorial Sloan Kettering Cancer Center leads trials for rare cancers
Lead Academic Participating Site: Memorial Sloan Kettering Cancer Center
This study is all about helping patients with rare cancers by offering them the chance to join exciting new clinical trials at Memorial Sloan Kettering Cancer Center, where they can explore innovative treatments and therapies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11251350 on NIH RePORTER |
What this research studies
This research focuses on maintaining Memorial Sloan Kettering Cancer Center's role as a leading site for the National Clinical Trials Network, specifically targeting rare cancers. The center aims to develop and support clinical trials that evaluate new treatments and therapies for these malignancies. By leveraging its extensive resources and expertise, MSK will contribute to patient recruitment for trials and provide mentorship to emerging researchers in the field. Patients may have the opportunity to participate in cutting-edge clinical trials that could lead to new treatment options.
Who could benefit from this research
Good fit: Ideal candidates for participation are individuals diagnosed with rare cancers who are seeking new treatment options.
Not a fit: Patients with common cancers or those who are not eligible for clinical trials may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with access to innovative therapies for rare cancers that are currently under-researched.
How similar studies have performed: Previous research has shown success in developing effective treatments through similar clinical trial networks, indicating a promising approach.
Where this research is happening
New York, United States
- Sloan-Kettering Inst Can Research — New York, United States (Active)
Researchers
- Principal investigator: Aghajanian, Carol — Sloan-Kettering Inst Can Research
- Study coordinator: Aghajanian, Carol
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.